Skip to main content

Socio–economic costs of migraine


Migraine is one of the most common neurological diseases afflicting 12% of general population but is poorly recognized and largely untreated. Migraine is a disabling disease with very high social costs as it affects young individuals during their productive age. Quality of life in migraineurs is impaired. Furthermore, the economic burden of migraine, usually evaluated in terms of direct and indirect costs, is relevant and could be reduced by an early diagnosis and an appropriate treatment.

Author information



Corresponding author

Correspondence to Rosanna Cerbo.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Cerbo, R., Pesare, M., Aurilia, C. et al. Socio–economic costs of migraine. J Headache Pain 2, s15–s19 (2001).

Download citation

Key words

  • Pharmacoeconomics
  • Migraine